CIRCULOGENE is the leader in molecular testing. By applying proprietary cell-free DNA recovery and enrichment technology, CIRCULOGENE is the first and only company to use minimal-volumes of blood to monitor tumors and the first company to develop a next-generation sequencing method to provide full genomic load analysis. CIRCULOGENE is founded and operated by leaders and scientists from the diagnostics industry.


Dr. Paul Walker | Chair

Dr. Paul Walker is director of Thoracic Oncology at East Carolina University and has been the past Program Director and Chief of Hematology/Oncology for the Brody School of Medicine as well as the Medical Director for the Clinical Trials Office. Dr. Walker’s has multiple medical journal publications including cancer biotherapy with breast and lung cancers. Dr. Walker has been the principal investigator on multiple clinical trials including immune therapy, immune modulating and boosting therapies. He earned his medical degree from Indiana University School of Medicine, completed his residence at Ball Memorial Hospital, and his medical oncology fellowship at the Medical College of Ohio.


Dr. Richard Lanman

Dr. Lanman was most recently the Global Chief Medical Officer at Guardant Health where he planned and executed research studies, publications, and physician education in oncology genomics required to obtain their broad insurance coverage, incorporation in clinical guidelines and FDA approvals and clearances. Dr. Lanman served similar capacities as the Chief Medical Officer at cytology-based genomics testing company Veracyte as well as at two cardiovascular bio-diagnostics companies, diaDexus and Atherotech. Dr. Lanman graduated Stanford with a B.S. in Chemistry before obtaining his M.D. at Northwestern University School of Medicine and completing his residency at UCSF Moffit Hospital. 


Dr. James Cantrell

Dr. James Cantrell has practiced Oncology-Hematology over 30 years and was a co-founder and President of Alabama Oncology, LLC and Medical Director of the Bruno Cancer Center. He has published over 20 peer reviewed articles and abstracts, and has been a member of numerous professional organizations, including the US Oncology Research Program. He earned his MD and completed an Internal Medicine Residency at Emory University School of Medicine, and Fellowships in Medical Oncology and Hematology at Georgetown University Hospital.